Know Cancer

or
forgot password


N/A
18 Years
95 Years
Open (Enrolling)
Both
Pulmonary Sarcoidosis

Thank you

Trial Information


Inclusion Criteria:



- Stable pulmonary sarcoidosis with no change in medication during the last 3 months.

Exclusion Criteria:

- Any significant other pulmonary and\or co-morbidity that can affect exercise
tolerance.

- Chronic steroid treatment more than 5 mg/day.

- Previous lung surgery.

- Advanced heart failure (NYHA III-IV )

- Malignancy during the last 3 years

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Improvment in 6 minute walking distance and VO2/KG max following pulmonary rehabilitation.

Outcome Time Frame:

16 weeks

Safety Issue:

No

Authority:

Israel: Ethics Commission

Study ID:

0019-11-MMC

NCT ID:

NCT01384123

Start Date:

August 2011

Completion Date:

July 2013

Related Keywords:

  • Pulmonary Sarcoidosis
  • stable pulmonary sarcoidosis with no change in medication during the last 3 months/
  • Sarcoidosis
  • Sarcoidosis, Pulmonary

Name

Location